Role of Propolis Endodontic Irrigant on Post-Operative Pain

Sponsor
Dow University of Health Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT05974748
Collaborator
(none)
44
1
2
5
8.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare propolis and sodium hypochlorite as endodontic irrigants in patients presenting with symptomatic irreversible pulpitis.

. The main question it aims to answer is:

• if there is any analgesic effects of 20% Propolis compared with 5.25% NaOCl on the intensity of post-operative pain in patients with symptomatic irreversible pulpitis using VAS pain score. Participants will undergo root canal treatment of their teeth using either 20% propolis solution or 5.25% NaOCl in their first visit of a multi-visit root canal treatment.

Researchers will compare 20% Propolis and 5.25% NaOCl to see reduction in Intensity of Post-Operative Pain using visual analogue scale over 72 hour duration.

Condition or Disease Intervention/Treatment Phase
  • Drug: Sodium hypochlorite 5.25%
  • Drug: Propolis 20%
Phase 3

Detailed Description

Sodium hypochlorite as an endodontic irrigant, poses problems of toxicity. Additionally, its unfavorable odor, taste, failure to remove the smear layer, and proteolytic effect have deleterious effects on the dentine, creating unfavorable structural and mechanical alterations . To get beyond NaOCl limits and adverse effects, it is necessary to look for a biocompatible, equally effective, and dentine friendly irrigant with greater patient acceptance in taste and odor.

The literature lacks an in-vivo study that investigates the anti-inflammatory with analgesic characteristics of Propolis on post-endodontic pain as an irrigant, in patients with symptomatic irreversible pulpitis. This research will endeavor to fill this gap in literature.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 interventional groups assigned. 1 will be receiving routine intervention and other is the experimental group.2 interventional groups assigned. 1 will be receiving routine intervention and other is the experimental group.
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants will not be aware of their interventional group. A proforma and pain intensity scale will be provided to the patient by an intern not involved in the study, to be completed at 24, 48, and 72 hours following the procedure to assess post-operative pain. this proforma will be collected and assessed by the intern.
Primary Purpose:
Prevention
Official Title:
Comparative Evaluation of Propolis and Sodium Hypochlorite as Endodontic Irrigants on Post-Operative Pain in Patients With Symptomatic Irreversible Pulpitis
Actual Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Jul 30, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sodium Hypochlorite

5.25% sodium hypochlorite is the gold standard endodontic irrigant. Other Name: NaOCl

Drug: Sodium hypochlorite 5.25%
The participants will be randomly divided into two groups using the sealed envelope method during the instrumentation process. The clinician will use the irrigation in accordance with the protocol. Between each instrument in group A, 3 ml of 5.25% sodium hypochlorite (NaOCl) will be used to irrigate each canal.
Other Names:
  • NaOCl
  • Experimental: Propolis

    Hydroalcoholic 20% propolis will be used as an endodontic irrigant. Other Name: Bee glue

    Drug: Propolis 20%
    In group B, a 20% hydroalcoholic propolis solution of 3 milliliters will be used to irrigate each canal, between each instrument.
    Other Names:
  • Bee glue
  • Outcome Measures

    Primary Outcome Measures

    1. Change in post-operative pain intensity on visual analogue scale(0-10) [24 hours, 48 hours and 72 hours]

      Self recorded by patient and then assessed by an intern on a visual analogue scale of 0-10 with 0 being no pain , 10 being worst pain

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. ASA-I and II individuals who are between the ages of 18 and 60 years.

    2. Patients with mandibular and maxillary premolars who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis).

    3. Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS=1-10)

    Exclusion Criteria:
    1. Patients suffering from severe pain because of traumatic occlusion.

    2. Teeth with extensive damage, calcified canals, periapical radiolucency, root resorption, and an open apex.

    3. Patients with compromised medical condition (ASA-III and above)

    4. Patients who are unable to communicate effectively in either Urdu or English.

    5. Pregnant and lactating ladies

    6. Patients who are allergic to honey or bee pollen.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dow International Dental College Karachi Sindh Pakistan 75500

    Sponsors and Collaborators

    • Dow University of Health Sciences

    Investigators

    • Principal Investigator: Tayyaba Tahira, BDS FCPS, Dow International Dental College, Dow University of Health Sciences
    • Study Director: Farah Naz, BDS FCPS, Dow International Dental College, Dow University of Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tayyaba Tahira, Lecturer, Dow University of Health Sciences
    ClinicalTrials.gov Identifier:
    NCT05974748
    Other Study ID Numbers:
    • 2908
    First Posted:
    Aug 3, 2023
    Last Update Posted:
    Aug 3, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Tayyaba Tahira, Lecturer, Dow University of Health Sciences
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2023